OCRELIZUMAB

UNII:	A10SJL62JY
Formula:
Preferred Substance Name:	OCRELIZUMAB

637334-45-3
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
OCRELIZUMAB [INN]
OCRELIZUMAB [JAN]
OCRELIZUMAB [MI]
OCRELIZUMAB [PURPLE BOOK CDER]
OCRELIZUMAB [USAN]
OCRELIZUMAB [WHO-DD]
OCRELIZUMAB-OCSQ
OCREVUS
OCREVUS ZUNOVO COMPONENT OCRELIZUMAB
PR070769
PR-070769
R-1594
RG-1594

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OCRELIZUMAB

Synonyms and Mappings

Resources